1,318
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Case Report

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case

, , , , ORCID Icon & ORCID Icon
Article: 2093075 | Received 02 May 2022, Accepted 19 Jun 2022, Published online: 25 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.